Chief Scientific Officer
A co-founding partner of Bio Therapeutic Molecules Inc. (BTMI), Vince has over 20 years of experience spanning early product development to commercialization. A proven leader with a track record of tying together the science, regulatory and business aspects of a given situation in order to define strategic direction for companies, programs and projects. This has resulted in the commercialization of numerous products with big and small pharma, nutritional and consumer goods companies.
Vince started his career as a Research Scientist at GlaxoSmithKline (GSK). Over his 8+ years with GSK he held positions of increasing responsibility in various departments including Pharmaceutical Research, Pharmaceutical Science (product development), New Business Development and Global Manufacturing and Supply. Following this Vince joined Eli Lilly where for over 4 years he led the Canadian research laboratories, as the Associate Director of the Lilly Laboratories for Analytical Research and Bioanalytical Research, in the development of small molecules and bioproducts. Prior to establishing BTMI, Vince was a member of the Executive Team at Accucaps Industries Ltd. for almost 10 years, with various responsibilities over time for Quality, Regulatory Affairs and Research and Development. During this time, he defined and implemented the strategy to transform Accucaps from a Contract Manufacturing Organization, which manufactured predominately commodity OTC and consumer products, into an FDA approved Contract Development and Manufacturing Organization that develops products for big and small pharma as well as delivering novel in-house development.